Accelerate Diagnostics is an in vitro diagnostics company engaged in providing solutions that develop patient outcomes through the diagnosis of serious infections. The Company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms, as well as yeast.

Type
Public
HQ
Tucson, US
Founded
2004
Size (employees)
193 (est)
Accelerate Diagnostics was founded in 2004 and is headquartered in Tucson, US
Report incorrect company information

Key People/Management at Accelerate Diagnostics

Lawrence Mehren

Lawrence Mehren

President, Chief Executive Officer & Director
Steve Reichling

Steve Reichling

CFO
Kurt Reinhardt

Kurt Reinhardt

Head of Operations
Steve Metzger

Steve Metzger

Head of Discovery
Andrew Ghusson

Andrew Ghusson

Head of Product Development
Pete Bantock

Pete Bantock

Head of Clinical Intervention Solutions
Show more

Accelerate Diagnostics Office Locations

Accelerate Diagnostics has offices in Tucson and Castelldefels
Tucson, US (HQ)
3950 S Country Club Rd
Castelldefels, ES
1 Carrer Esteve Terradas
Show all (2)
Report incorrect company information

Accelerate Diagnostics Financials and Metrics

Accelerate Diagnostics Financials

Accelerate Diagnostics's revenue was reported to be $4.18 m in FY, 2017
USD

Revenue (Q1, 2018)

801 k

Gross profit (Q1, 2018)

309 k

Gross profit margin (Q1, 2018), %

38.6%

Net income (Q1, 2018)

(20.8 m)

EBIT (Q1, 2018)

(20.8 m)

Market capitalization (14-Jun-2018)

1.2 b

Closing share price (14-Jun-2018)

23

Cash (31-Mar-2018)

126.8 m
Accelerate Diagnostics's current market capitalization is $1.2 b.
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Revenue

48.3 k122 k147 k246 k4.2 m

Revenue growth, %

153%20%67%

Cost of goods sold

1 m

Gross profit

3.2 m
Quarterly
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q3, 2016Q1, 2017Q2, 2017Q1, 2018

Revenue

13 k14 k92 k163 k801 k

Cost of goods sold

492 k

Gross profit

309 k

Gross profit Margin, %

39%
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Cash

30 m53.6 m120.6 m19.2 m28.5 m

Accounts Receivable

24.4 k78 k77 k155.7 m

Inventories

8.1 m

Current Assets

42.1 m67.1 m134.2 m78.4 m120.5 m
Quarterly
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q1, 2018

Cash

65.2 m57.9 m47.4 m35.2 k25.2 m72 m37.5 m28.7 m9.9 m62.6 m126.8 m

Inventories

4.4 m5.7 m10.1 m

Current Assets

79.7 m72.7 m59.7 m49.4 k40.9 m120.3 m105.4 m91.7 m70.3 m143.3 m207.1 m

PP&E

1.9 m2.3 m3.5 m3.8 k3.7 m5.2 m5 m4.8 m3.9 m4.8 m5.9 m
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

(3.4 m)(3.4 m)(45.5 m)(66.4 m)(64 m)

Depreciation and Amortization

42.7 k43 k1.8 m2.4 m2.2 m

Inventories

10.3 k10 k(7.8 m)

Accounts Payable

236.6 k236 k329 k(1.2 m)1.1 m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q1, 2018

Net Income

(8.2 m)(22.2 m)(8.9 m)(21.1 m)(11.2 m)(15.1 m)(50.2 m)(14.2 m)(20.8 m)

Depreciation and Amortization

150 k592 k326 k5 k468 k545 k8 k3 k544 k

Inventories

4.4 m(1.9 m)

Accounts Payable

6.8 k718 k1.3 m528 k2.4 m1.7 k1.6 m494 k1.8 m2.4 m1.3 m701 k
USDY, 2018

Revenue/Employee

4.2 k

Financial Leverage

2 x
Show all financial metrics
Report incorrect company information

Accelerate Diagnostics Online and Social Media Presence

Embed Graph
Report incorrect company information

Accelerate Diagnostics News and Updates

Report incorrect company information